An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
AngioDynamics to Participate in Three Investor Conferences in March
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology leader, announced participation in three investor conferences in March 2023. The Raymond James Institutional Investors Conference will be held on March 6 at 8:05 a.m. ET in Orlando, FL. Following that, AngioDynamics will engage in a Fireside Chat at the Oppenheimer Virtual Healthcare Conference on March 13 at 9:20 a.m. ET. Lastly, they will present at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on March 21 at 4:30 p.m. ET. Live webcasts will be available on their website, with replays after each event.
Positive
None.
Negative
None.
LATHAM, N.Y.--(BUSINESS WIRE)--
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will participate in the following three investor conferences in March:
Raymond James Institutional Investors Conference Format: In-person Presentation
Date: Monday, March 6, 2023 Time: 8:05 a.m. ET Location: Orlando, FL
Oppenheimer Virtual Healthcare Conference Format: Fireside Chat
Date: Monday, March 13, 2023 Time: 9:20 a.m. ET
KeyBanc Virtual Life Sciences & MedTech Investor Forum Format: Fireside Chat
Date: Tuesday, March 21, 2023 Time: 4:30 p.m. ET
A live webcast of each presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following each event.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.
The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.
AngioDynamics, Inc. Stephen Trowbridge, Executive Vice President & CFO
(518) 795-1408
Source: AngioDynamics, Inc.
FAQ
What investor conferences is AngioDynamics participating in March 2023?
AngioDynamics is participating in the Raymond James Institutional Investors Conference on March 6, the Oppenheimer Virtual Healthcare Conference on March 13, and the KeyBanc Virtual Life Sciences & MedTech Investor Forum on March 21.
When and where is the Raymond James Institutional Investors Conference?
The Raymond James Institutional Investors Conference is on March 6, 2023, at 8:05 a.m. ET in Orlando, FL.
What format will the Oppenheimer Virtual Healthcare Conference take?
The Oppenheimer Virtual Healthcare Conference will feature a Fireside Chat on March 13, 2023, at 9:20 a.m. ET.
Where can I watch the live webcast of AngioDynamics' presentations?
Live webcasts of AngioDynamics' presentations will be accessible via the Investors section of their website at www.angiodynamics.com.
What is AngioDynamics' focus as a medical technology company?
AngioDynamics focuses on restoring healthy blood flow, expanding cancer treatment options, and improving patient quality of life.
